Question 1

What specific criteria do I need to meet to participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma clinical trial (NCT03690310). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma clinical trial (NCT03690310). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the anti-CD19 CAR NK cells?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma clinical trial (NCT03690310). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma clinical trial (NCT03690310). Contact the study team or your healthcare provider for specific answers.

Question 5

What monitoring will be involved during the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma clinical trial (NCT03690310). Contact the study team or your healthcare provider for specific answers.

Question 6

How will this treatment fit into my overall cancer care plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma clinical trial (NCT03690310). Contact the study team or your healthcare provider for specific answers.

Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma

What this study is about

Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma

What this study is about